Adam Sragovicz

Adam Sragovicz is a seasoned Chief Financial Officer with extensive experience leading financial strategies, IPOs, mergers and acquisitions, and driving growth across diverse industries, including capital markets and biotech.

Adam Sragovicz is a highly accomplished Chief Financial Officer with extensive experience leading financial strategies, IPOs, mergers and acquisitions, and driving growth across diverse industries, including capital markets and biotech. With a proven track record in navigating complex financial environments, he successfully led a $132 million SPAC IPO and a $720 million business combination, while also taking a commercial real estate company public during the COVID-19 pandemic. Fluent in Russian and Spanish, Adam brings international expertise and a passion for innovation to his role as a strategic financial leader.

Avimer Bio is pioneering the next generation of targeted medicines for severe immune and inflammatory diseases by harnessing nature’s own structural principles. Our proprietary, fully-human nanocage technology delivers potent and selective activation of regulatory T cells (Tregs)—the body’s master regulators of immune balance—offering the potential for true disease modification in conditions like atopic dermatitis, ulcerative colitis, and beyond.

Unlike traditional therapies, Avimer Bio’s AI-designed nanocages precisely cluster and activate key receptors such as TNFR2, replicating the geometry and avidity [binding strength] of natural cell signaling for superior efficacy and safety. This approach enables tissue-specific Treg expansion and immunoregulation without unwanted immune activation, aiming for durable remission rather than symptomatic relief.

With a proven leadership team in protein engineering and structural biology, a robust IP portfolio, and early clinical focus on high-need indications, Avimer Bio is now seeking funding to advance its lead candidate and fast-follower programs. We are not just developing new drugs—we are enabling a paradigm shift in how immune and inflammatory diseases are treated, with broad applications across dermatology, gastroenterology, rheumatology, and neuroinflammation.

Avimer Bio: Nature’s structure, reimagined for transformative medicines.